MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. - Wikidata - wikimedia - TriplyDB

MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

http://www.wikidata.org/entity/Q36154032

about

Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1gfp/gfp mice Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.Cerebellar Dysfunction in Multiple Sclerosis.Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.Novel therapeutic approach by nicotine in experimental model of multiple sclerosis.Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.The role of chromogranin B in an animal model of multiple sclerosis.Purkinje cell loss in experimental autoimmune encephalomyelitis.Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.Immune characteristics study of AG490, a signal pathway inhibitor, in EAE model mice The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.Role of inactivated influenza vaccine in regulation of autoimmune processes in experimental autoimmune encephalomyelitis.Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.The enteric nervous system is a potential autoimmune target in multiple sclerosis.Microsomal Prostaglandin E Synthase-1 Facilitates an Intercellular Interaction between CD4⁺ T Cells through IL-1β Autocrine Function in Experimental Autoimmune Encephalomyelitis.Therapeutic effects of walnut oil on the animal model of multiple sclerosis.Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4 Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis

P2860

Q28394597-E00E8B72-B784-4498-A7B4-EC0722CF050A Q30840308-CA7F60CB-09EB-4D44-B3A6-EF29EDA18580 Q33682239-79813652-3E84-4853-9078-64C2FD499535 Q33728244-B14CC264-413B-4138-BB24-899693F050F9 Q33843083-EA8C20FC-9537-468B-80D0-B800958EAD68 Q33911142-260AEDB5-AB96-4B3E-B967-AE97D816938C Q34146191-488878D9-5B86-4480-A631-1A1CD2054A9C Q34192160-F20D9F21-D020-4380-88DC-3FFADB05B280 Q35145298-C716E81F-C30D-44A6-85A3-A488F599D100 Q35800253-73EB1D4E-E4EE-4A0F-A598-350029675369 Q35867011-22AD25B8-8BC7-4A87-A6CC-F0A8DCB9AEF3 Q36750834-18D4C9F3-C7A2-4A8C-9C08-B6947C706947 Q36859084-5D7A3832-D1F3-4C98-8094-8AFF7C6FF9CD Q36990042-5D577B0D-5666-4041-8BBC-24F56E769649 Q37216886-A851FB87-2078-4023-8F24-445D071FE7B8 Q37368941-353F93CA-176C-4581-B8D9-9E0E93D8D605 Q37388654-49B78954-3E7E-43BF-8D99-37045DB7045A Q37610907-BEC34752-5C43-4710-A653-96F31F611962 Q38059361-0EA6EB93-33ED-4C23-831E-33CEBF153C7A Q40466907-897C02A7-9C26-49E1-9786-29B1513E5DC5 Q43736164-AA922CD6-B157-4F53-80D1-1E3F476082A7 Q43887998-95BB1373-4526-4C53-A553-EA55F0FD2481 Q44565890-A6067742-360B-4B5E-A65F-05A226399DCD Q46816215-4484E3B9-B952-42EE-8E80-DD0ECC234208 Q47912566-042AFBB6-64BD-473B-9E21-D873B09C2EFB Q48013469-8674DB33-F982-422C-B17E-68E8BA492D60 Q48094913-043C8739-07A1-493C-B4F9-1BD18B515DC7 Q48096032-F3547200-97B9-43A9-A04C-6721801B05F1 Q48792301-D8EDC3F2-0300-4E4A-930A-C149E208C8DE Q49543789-7D69F112-0593-410E-AB7F-0D4BA13AC3B4 Q56889385-38ED263D-DD4C-4247-B4BF-2C601DFFD26B Q58122911-901F0D19-E057-4610-8942-7FDAD9FD3396 Q58788563-88A36E10-BE2C-40B9-B745-F6AE1A8547AE

P2860

MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

http://www.wikidata.org/entity/Q36154032

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@ast

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@en

type

label

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@ast

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@en

prefLabel

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@ast

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@en

P1433

Q36154032-E39A9D57-92A7-43D8-BB2A-356D6F0D3AFE

P1476

Q36154032-45E78DE1-E87E-4BAB-9878-E74F4FFA9862

P2093

Q36154032-00BC718B-41B2-4527-B308-FC0F4194CA07

Q36154032-4465C80D-0B11-4C57-8454-54F959550175

Q36154032-67442990-6085-4593-86B5-EC676DAA1141

Q36154032-8751FB99-B542-4208-BDBD-49901CC38058

Q36154032-959435C8-B7F4-4A89-87BB-3BBD1E64BDDA

Q36154032-B865457F-04C8-4C6E-A77E-594EE0FD75E2

Q36154032-BF81F8AD-D178-441C-909E-ED966F8CB220

P2860

Q36154032-02814638-1DE2-4E69-A422-6F29DB9AC464

Q36154032-0AAAB032-A0DD-4D5A-BFB0-8E8F83C607E9

Q36154032-12A8B5C8-5DF2-432D-A714-B58A59DE529E

Q36154032-13250FE5-6BED-4A7A-9710-0122B4FB2B88

Q36154032-14C559CC-DB22-4F14-A56F-9FD5BF565395

Q36154032-1B1EB309-1862-45AC-8CD6-384FAAD2F446

Q36154032-27862492-5A85-4626-87F2-307FCCA28E55

Q36154032-2FA6BA21-5289-4735-8DEC-BE25359673BA

Q36154032-342C4922-634B-4015-85B2-60970F8636C2

Q36154032-4FF72D67-DDC9-4276-A5B4-0FA6278B4451

P304

Q36154032-08097939-AA43-4310-8AEB-7313A2013FA0

P31

Q36154032-3430D572-7FB1-4F83-82B2-1907B28F7DE2

P356

Q36154032-F63C2D05-5BAA-49DD-8DC8-5A9F5E0249B2

P433

Q36154032-7EDFAEC1-D64F-49E0-93C8-F40984539AAA

P478

Q36154032-0AD281A7-7E69-4D0A-BD2E-EC3F742C2091

P577

Q36154032-3D30DDC4-07F8-42ED-81EA-5D51F5039382

P5875

Q36154032-3E8F805E-FD33-42D8-8379-EB1EC54B26C7

P698

Q36154032-1C640DAF-7339-4FD0-BED5-AFDF53F1AB29

P932

Q36154032-18DB4638-E451-43AE-852C-9403AFACB9A0

P356

J.JNEUROIM.2007.06.016

P1433

Journal of Neuroimmunology

P1476

MP4- and MOG:35-55-induced EAE ...... n, spinal cord and cerebellum.

@en

P2093

Dilyana A Kostova-Bales

http://www.w3.org/2001/XMLSchema#string

Doychin N Angelov

http://www.w3.org/2001/XMLSchema#string

Justine T Tigno

http://www.w3.org/2001/XMLSchema#string

Lukas P Frenzel

http://www.w3.org/2001/XMLSchema#string

Magdalena Tary-Lehmann

http://www.w3.org/2001/XMLSchema#string

Paul V Lehmann

http://www.w3.org/2001/XMLSchema#string

Stefanie Kuerten

http://www.w3.org/2001/XMLSchema#string

P2860

Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Candidate autoantigens in multiple sclerosis.

Assessment of animal models for MS and demyelinating disease in the design of rational therapy.

Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis

Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis.

The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal.

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

The pathology of multiple sclerosis: a paradigm shift.

P304

31-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2007.06.016

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6182789

http://www.w3.org/2001/XMLSchema#string

P698

17655940

http://www.w3.org/2001/XMLSchema#string

P932

2083209

http://www.w3.org/2001/XMLSchema#string